EMA reviews Ixiaro following recall, annuls potency concerns

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1395, 2012-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

No safety concerns with Rotarix concludes EMA

By  

Reactions Weekly, Vol. 1, Iss. 1295-1296, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Cannabis Concerns: Increased Potency, Availability and Synthetic Analogues

By  

Current Drug Abuse Reviews, Vol. 7, Iss. 2, 2014-08 ,pp. : 67-68

Bentham Science Publishers

Access to resources Recommend Favorite

Glivec EU-SPC updated following safety concerns

By  

Reactions Weekly, Vol. 1, Iss. 1135, 2007-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Glivec EU-SPC updated following safety concerns

By  

Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Docetaxel: Erythema following extravasation, leading to recall dermatitis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1345, 2011-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite